Dan Xie

2.0k total citations
45 papers, 1.5k citations indexed

About

Dan Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dan Xie has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Dan Xie's work include MicroRNA in disease regulation (9 papers), Microbial Natural Products and Biosynthesis (6 papers) and Cancer-related molecular mechanisms research (6 papers). Dan Xie is often cited by papers focused on MicroRNA in disease regulation (9 papers), Microbial Natural Products and Biosynthesis (6 papers) and Cancer-related molecular mechanisms research (6 papers). Dan Xie collaborates with scholars based in China, United States and Hong Kong. Dan Xie's co-authors include Lin Fang, Tianqi Wu, Jiashu Hu, Hongming Song, Jungui Dai, Yi-Xin Zeng, Hsiang‐Fu Kung, Xiu‐Wu Bian, Xin‐Yuan Guan and Yiji Liao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Dan Xie

42 papers receiving 1.5k citations

Peers

Dan Xie
Shu‐Wing Ng United States
Yi Luo China
Xianzhong Ding United States
Rishi Raj Chhipa United States
Linda Beltrán United States
Mohamad Elbaz United States
Shu‐Wing Ng United States
Dan Xie
Citations per year, relative to Dan Xie Dan Xie (= 1×) peers Shu‐Wing Ng

Countries citing papers authored by Dan Xie

Since Specialization
Citations

This map shows the geographic impact of Dan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Xie more than expected).

Fields of papers citing papers by Dan Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Xie. The network helps show where Dan Xie may publish in the future.

Co-authorship network of co-authors of Dan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Xie. A scholar is included among the top collaborators of Dan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Xie. Dan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qiang, Chunyan Wang, Fang Zhang, et al.. (2025). Balancing act: How community measures shape environmental risk perceptions and preventive behaviours during the COVID-19 pandemic. Environmental Impact Assessment Review. 115. 108062–108062.
2.
Ali, Eslam M.H., et al.. (2023). Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers. Bioorganic & Medicinal Chemistry Letters. 95. 129485–129485. 5 indexed citations
4.
Xie, Dan, et al.. (2022). MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4. Pathology - Research and Practice. 230. 153763–153763. 18 indexed citations
5.
Chen, Yi‐Ming, Jingjing Qiu, Shunli Tang, et al.. (2017). Research on the inhibitory effect of metformin on human oral squamous cell carcinoma SCC-4 and CAL-27 cells and the relevant molecular mechanism. Biomedical Research-tokyo. 28(14). 6350–6354. 1 indexed citations
6.
Li, Deng‐Feng, Hongming Song, Tianqi Wu, et al.. (2017). MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1. Molecular and Cellular Biochemistry. 444(1-2). 169–178. 37 indexed citations
7.
Zhang, Jiaxing, Zhenhua Chen, Yi Xu, et al.. (2016). Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2. Clinical Cancer Research. 23(1). 298–310. 51 indexed citations
8.
McLaren, David G., Stephen F. Previs, Robert D. Phair, et al.. (2016). Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux. Journal of Lipid Research. 57(3). 398–409. 9 indexed citations
9.
Zhao, Lei, Yingxue Wang, Xiao-Peng Tian, et al.. (2015). Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma. Scientific Reports. 5(1). 17336–17336. 15 indexed citations
10.
Haeusler, Rebecca A., Stefania Camastra, Monica Nannipieri, et al.. (2015). Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity. The Journal of Clinical Endocrinology & Metabolism. 101(5). 1935–1944. 111 indexed citations
11.
Zhang, Nan, Guiling Sun, Angela Hoffman, et al.. (2014). Molecular cloning and characterization of a cytochrome P450 taxoid 9á-hydroxylase in Ginkgo biloba cells. Biochemical and Biophysical Research Communications. 443(3). 938–943. 19 indexed citations
13.
Liu, Lulu, Yongdong Dai, Jinna Chen, et al.. (2013). Maelstrom Promotes Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition by Way of Akt/GSK-3β/Snail Signaling. Hepatology. 59(2). 531–543. 105 indexed citations
14.
Han, Seongah, Paul Fischer, Shengping Wang, et al.. (2012). Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 825–833. 16 indexed citations
15.
Wu, Zhicai, Thomas H. Graham, Andreas Verras, et al.. (2012). Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(4). 1727–1730. 4 indexed citations
16.
Cai, Qingqing, et al.. (2012). Phosphorylated AKT Protein Is Overexpressed in Human Peripheral T-cell Lymphomas and Predicts Decreased Patient Survival. Clinical Lymphoma Myeloma & Leukemia. 12(2). 106–112. 13 indexed citations
17.
Chen, Zhu, José Castro‐Perez, Weihua Ni, et al.. (2011). AAV8-Mediated Long-Term Expression of Human LCAT Significantly Improves Lipid Profiles in hCETP;Ldlr+/− Mice. Journal of Cardiovascular Translational Research. 4(6). 801–810. 15 indexed citations
18.
Zheng, Fang, Yiji Liao, Mu-Yan Cai, et al.. (2011). The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61(2). 278–289. 327 indexed citations
19.
Xie, Dan, Hongting Jia, Yi Zhang, et al.. (2009). Four new minor taxanes from cell cultures ofTaxus chinensis. Journal of Asian Natural Products Research. 11(6). 490–497. 3 indexed citations
20.
Qureshi, Sajjad A., Victor Ding, Zhihua Li, et al.. (2000). Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators. Journal of Biological Chemistry. 275(47). 36590–36595. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026